.webp)
37/100BAmeren stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Ameren is 114.10, 0.2% below the current price of 114.34. Their targets range from 104.00 to 126.00.
Of the 14 firms that rated Ameren in the past 12 months, 9 rate it buy or strong buy, 5 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 104.00 to 126.00, with an average of 114.10.
| Buy | 9 | |
| Hold | 5 | |
| Sell | 0 |
12-month price target
| Highest target | 126.00 |
| Average target | 114.10 |
| Lowest target | 104.00 |
| Current price | 114.34 |
Ameren price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Ameren price target and rating?
How analysts rate Ameren, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
9 of 14 firms rate it buy now, against 5 of 9 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Ameren analyst upgrades, downgrades and price targets
The latest rating change came on 23 July 2026, when KeyBanc upgraded Ameren from Sector Weight to Overweight. Its price target is 122.00, from 109.00. The most recent new target came from Mizuho Securities on 9 November 2026: 123.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 9 Nov 2026 | Mizuho Securities Anthony Crowdel | Reiterated · Outperform | 113.00 → 123.00 | +8.8% | 112.85 |
| 22 Oct 2026 | HSBC Meike Becker | — | 119.10 | — | 106.48 |
| 21 Oct 2026 | Morgan Stanley | Reiterated · Equal Weight | 118.00 → 109.00 | -7.6% | 106.67 |
| 20 Oct 2026 | BMO Capital James Thalacker | Reiterated · Outperform | 120.00 → 113.00 | -5.8% | 105.75 |
| 20 Oct 2026 | Industrial Alliance Securities | — | 113.00 | — | 105.87 |
| 19 Oct 2026 | Barclays Nicholas Campanella | Reiterated · Equal Weight | 117.00 → 109.00 | -6.8% | 106.08 |
| 14 Oct 2026 | Truist Financial | Reiterated · Buy | 120.00 → 116.00 | -3.3% | 104.32 |
| 13 Oct 2026 | KeyBanc Sophie Karp | Reiterated · Overweight | 122.00 → 116.00 | -4.9% | 103.24 |
| 30 Sept 2026 | Mizuho Securities Anthony Crowdel | Reiterated · Outperform | 124.00 → 113.00 | -8.9% | 100.25 |
| 29 Sept 2026 | Scotiabank Ian Rapp | — | 104.00 | — | 99.39 |
| 25 Sept 2026 | RBC Capital Stephen D\'Ambrisi | Reiterated · Sector Perform | 116.00 → 107.00 | -7.8% | 98.46 |
| 17 Aug 2026 | Truist Financial | Reiterated · Buy | 126.00 → 120.00 | -4.8% | 109.74 |
| 3 Aug 2026 | Mizuho Securities | Reiterated · Outperform | 117.00 → 124.00 | +6.0% | 109.61 |
| 23 Jul 2026 | BTIG | — | 131.00 → 126.00 | -3.8% | 112.01 |
| 23 Jul 2026 | KeyBanc | Upgraded · Sector Weight → Overweight | 109.00 → 122.00 | +11.9% | 112.01 |
| 22 Jul 2026 | Morgan Stanley | Reiterated · Equal Weight | 115.00 → 118.00 | +2.6% | 111.37 |
| 9 Jul 2026 | Barclays Nicholas Campanella | Reiterated · Equal Weight | 116.00 → 117.00 | +0.9% | 112.54 |
| 24 Jun 2026 | Morgan Stanley David Arcaro | — | 110.00 → 115.00 | +4.5% | 112.71 |
| 21 May 2026 | Morgan Stanley | — | 117.00 → 110.00 | -6.0% | 109.75 |
| 21 May 2026 | JP Morgan | Upgraded · Neutral → Overweight | — | — | — |
| 21 Apr 2026 | Morgan Stanley David Arcaro | Reiterated · Equal Weight | 116.00 → 117.00 | +0.9% | 110.69 |
| 21 Apr 2026 | Wells Fargo Shahriar Pourreza | — | 113.00 → 120.00 | +6.2% | 111.27 |
| 20 Apr 2026 | Truist Financial Richard Sunderland | — | 126.00 | — | 111.27 |
| 15 Apr 2026 | Barclays | Reiterated · Equal Weight | 104.00 → 116.00 | +11.5% | 111.86 |
| 9 Apr 2026 | BTIG Alex Kania | — | 131.00 | — | 114.32 |
| 20 Feb 2026 | Morgan Stanley David Arcaro | — | 108.00 → 116.00 | +7.4% | 109.46 |
| 20 Feb 2026 | UBS William Appicelli | Reiterated · Buy | 115.00 → 127.00 | +10.4% | 109.31 |
| 13 Feb 2026 | Wells Fargo | Reiterated · Overweight | 111.00 → 113.00 | +1.8% | 109.41 |
| 13 Feb 2026 | Mizuho Securities | — | 114.00 → 117.00 | +2.6% | 109.34 |
| 13 Feb 2026 | BMO Capital | Reiterated · Outperform | 120.00 | — | 109.34 |
| 23 Jan 2026 | RBC Capital Stephen D'Ambrisi | — | 119.00 → 116.00 | -2.5% | 101.85 |
| 21 Jan 2026 | Morgan Stanley David Arcaro | — | 103.00 → 108.00 | +4.9% | 103.75 |
| 20 Jan 2026 | Wells Fargo | Reiterated · Overweight | 112.00 → 111.00 | -0.9% | 104.00 |
| 15 Jan 2026 | Barclays Nicholas Campanella | Reiterated · Equal Weight | 111.00 → 104.00 | -6.3% | 102.54 |
| 17 Dec 2025 | UBS | Reiterated · Buy | 114.00 → 115.00 | +0.9% | 97.99 |
| 16 Dec 2025 | Morgan Stanley | — | 111.00 → 103.00 | -7.2% | 98.87 |
| 12 Dec 2025 | Keybanc | Downgraded · Overweight → Sector Weight | — | — | — |
Ameren EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Ameren's EPS to grow 5.8% a year until 2028, slower than over the last 5 years (8.9% a year) and the last 3 years (8.9%).
Analysts expect Ameren's revenue to grow 5.8% a year until 2028, about as fast as over the last 5 years (8.7% a year) and the last 3 years (3.4%).
Revenue
EPS
Does Ameren beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 3.7% off the result, either way, and their revenue estimate 8.0%, over the last 12 quarters.
- EPS beats
- 80 / 135
- Revenue beats
- 74 / 119
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +1.2%
- Since
- February 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 5 Nov 2026 | 2.29 | 2.42 | +5.7% | 2.82B | 2.88B | +2.1% |
| Q2 FY2026 | 30 Jul 2026 | 1.08 | 1.13 | +4.6% | 2.27B | 2.09B | -8.0% |
| Q1 FY2026 | 5 May 2026 | 1.18 | 1.28 | +8.5% | 2.24B | 2.18B | -3.0% |
| Q4 FY2025 | 11 Feb 2026 | 0.77 | 0.78 | +1.2% | 1.60B | 1.78B | +11.3% |
| Q3 FY2025 | 5 Nov 2025 | 2.11 | 2.17 | +2.8% | 2.48B | 2.70B | +8.7% |
| Q2 FY2025 | 31 Jul 2025 | 0.99 | 1.01 | +2.3% | 1.78B | 2.22B | +24.7% |
| Q1 FY2025 | 1 May 2025 | 1.07 | 1.07 | 0.0% | 1.92B | 2.10B | +9.4% |
| Q4 FY2024 | 13 Feb 2025 | 0.80 | 0.77 | -3.1% | 1.90B | 1.94B | +2.2% |
| Q3 FY2024 | 6 Nov 2024 | 1.91 | 1.87 | -2.1% | 2.17B | 2.17B | +0.1% |
| Q2 FY2024 | 1 Aug 2024 | 0.93 | 0.97 | +4.3% | 1.87B | 1.69B | -9.7% |
| Q1 FY2024 | 2 May 2024 | 1.06 | 0.98 | -7.5% | 2.19B | 1.82B | -17.0% |
| Q4 FY2023 | 22 Feb 2024 | 0.61 | 0.60 | -1.6% | 1.62B | 1.62B | 0.0% |
Ameren stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Ameren's earnings keep growing at the 8.0% a year analysts expect to FY2028, it would earn about 7.41 a share in FY2030. At the P/E it has traded at over the last five years (16.5 to 23.1) that is 122.31 to 170.77 a share, or 147.30 at its average P/E of 19.9. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 5.42 | 89.46 | 107.74 | 124.90 |
| FY2027 | 5.80 | 95.85 | 115.44 | 133.82 |
| FY2028 | 6.34 | 104.78 | 126.19 | 146.29 |
| FY2029 (extrapolated) | 6.85 | 113.20 | 136.34 | 158.05 |
| FY2030 (extrapolated) | 7.41 | 122.31 | 147.30 | 170.77 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 8.0% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (16.5, 19.9, 23.1).
Is Ameren stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Ameren's P/E of 19.7 is below the middle of its 5-year range (16.1 to 25.5, median 21.7). Analysts expect slower growth than in recent years, so the low P/E may be deserved. Buyers pay more for each point of growth than usual: a PEG of 3.4 on expected growth against 2.5 on its median P/E and past five years' growth. At its usual P/E (21.7 × EPS of 5.80), Ameren's fair value is 125.93; the price, 114.34, is 9.2% below it. Its forward P/E, on the consensus for FY2026, is 21.1.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (16.1 and 25.5). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 19.71
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 21.71
- Five-year P/E range
- 16.1 – 25.5
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 21.11
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 2.45
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- -0.2%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.850 | 71.4258Price 35.85193 | +99.2% | |
| 29.050 | 56.2634Price 29.0596 | +93.7% | |
| 241.000 | 464.49205Price 241.00627 | +92.7% | |
| 123.590 | 237.24178Price 123.59297 | +92.0% | |
| 161.400 | 305.52159Price 161.40396 | +89.3% | |
| 157.460 | 297.58169Price 157.46471 | +89.0% | |
| 217.560 | 405.38304Price 217.56507 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.